Opioid Prescribing After Cesarean Delivery

Completed · Not applicable

Conditions studied: Surgery, Opioid Use

In brief

The number of opioid overdose deaths in the United States has quadrupled in 15 years, a dramatic manifestation of the current opioid abuse epidemic. This rise parallels a sharp increase in the amount of legal prescription opioids dispensed. The abundance of prescription opioids available is a primary pathway for opioid abuse and diversion. Adjusting post- cesarean delivery opioid prescribing practices to better match actual patient need has the potential to reduce unused opioids available for diversion, nonmedical use, and development of chronic dependence, as well as reduce wasted resources.

Key facts

Study ID

NCT03168425

Run by

Vanderbilt University Medical Center

People needed

190

Starts

2017-06-14

Expected to finish

2017-09-21

Last updated by the study team

2019-06-03

Who can join

Age: 18 and older, up to 50. Sex: female. Healthy volunteers: accepted.

You may qualify if…

• Women 18-50 years old
• Women undergoing cesarean delivery at a single institution

You may not qualify if…

• Major post-surgical complications: cesarean hysterectomy, bowl or bladder injury, reoperation, ICU admission, wound infection or separation
• Chronic opioid use: Taking buprenorphine during pregnancy, taking an opioid for > 7 days during pregnancy.
• Non English or Spanish speaking

Where it is running

• Sarah Osmundson — Nashville, Tennessee, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.